Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sakalin Trisiriwanich"'
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisutthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 wit
Externí odkaz:
https://doaj.org/article/0629312cc945435bb6f6a4a61ad5c035
Autor:
Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom, Sompong Sapsutthipas, Rujipas Sirijatuphat, Orasri Wittawatmongkol, Sansnee Senawong, Surakameth Mahasirimongkol, Sakalin Trisiriwanich, Kulkanya Chokephaibulkit
Publikováno v:
Vaccine: X, Vol 10, Iss , Pp 100153- (2022)
Background: Inactivated vaccine (CoronaVac) and chimpanzee adenovirus-vector vaccine (ChAdOx1) have been widely used in resource-limited settings. However, the information on the reactogenicity and immunogenicity of these two vaccines in the same set
Externí odkaz:
https://doaj.org/article/3c35a05b20af4615be50ab5732a280fa
Autor:
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, Kaewta Rattanapisit, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Eakachai Prompetchara, Chutitorn Ketloy, Supranee Buranapraditkun, Wassana Wijagkanalan, Kittipan Tharakhet, Papatsara Kaewpang, Kantinan Leetanasaksakul, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Kiat Ruxrungtham, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Publikováno v:
Frontiers in Plant Science, Vol 12 (2021)
The emergence of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected global public health and economy. Despite the substantial efforts, only few vaccines are currently approved and s
Externí odkaz:
https://doaj.org/article/81a79f5c339541419da793cc68622f90
Autor:
Tuksin Jearanaiwitayakul, Suttikarn Apichirapokey, Runglawan Chawengkirttikul, Jitra Limthongkul, Mathurin Seesen, Phissinee Jakaew, Sakalin Trisiriwanich, Sompong Sapsutthipas, Panya Sunintaboon, Sukathida Ubol
Publikováno v:
Viruses, Vol 13, Iss 11, p 2202 (2021)
The COVID-19 pandemic has currently created an unprecedented threat to human society and global health. A rapid mass vaccination to create herd immunity against SARS-CoV-2 is a crucial measure to ease the spread of this disease. Here, we investigated
Externí odkaz:
https://doaj.org/article/1ccef95447414f188efbf174b17bb7f1
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisuthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Successful COVID-19 prevention requires additional measures beyond vaccination, social distancing, and masking. A nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (COVITRAP™) was developed to strengthen other COVID-19 preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8080ab7b66efaf78699de5510765094a
https://doi.org/10.1101/2022.10.04.22280574
https://doi.org/10.1101/2022.10.04.22280574
Autor:
Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom, Sompong Sapsutthipas, Rujipas Sirijatuphat, Orasri Wittawatmongkol, Sansnee Senawong, Surakameth Mahasirimongkol, Sakalin Trisiriwanich, Kulkanya Chokephaibulkit
Publikováno v:
Vaccine: X. 10
Inactivated vaccine (CoronaVac) and chimpanzee adenovirus-vector vaccine (ChAdOx1) have been widely used in resource-limited settings. However, the information on the reactogenicity and immunogenicity of these two vaccines in the same setting are lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006233b1efe386209a2761549a3993f6
https://pubmed.ncbi.nlm.nih.gov/35282410
https://pubmed.ncbi.nlm.nih.gov/35282410
Autor:
Panya Sunintaboon, Tuksin Jearanaiwitayakul, Jitra Limthongkul, Runglawan Chawengkirttikul, Sompong Sapsutthipas, Phissinee Jakaew, Mathurin Seesen, Suttikarn Apichirapokey, Sukathida Ubol, Sakalin Trisiriwanich
Publikováno v:
Viruses
Volume 13
Issue 11
Viruses, Vol 13, Iss 2202, p 2202 (2021)
Volume 13
Issue 11
Viruses, Vol 13, Iss 2202, p 2202 (2021)
The COVID-19 pandemic has currently created an unprecedented threat to human society and global health. A rapid mass vaccination to create herd immunity against SARS-CoV-2 is a crucial measure to ease the spread of this disease. Here, we investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a905f2c7241cfb8686feaac5301ef92
http://europepmc.org/articles/PMC8617950
http://europepmc.org/articles/PMC8617950
Autor:
Supaporn Phumiamorn, Rujipas Sirijatuphat, Surakameth Mahasirimongkol, Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Sompong Sapsutthipas, Sakalin Trisiriwanich, Kasama Sukapirom, Kulkanya Chokephaibulkit, Sansnee Senawong, Orasri Wittawatmongkol
ImportanceInactivated vaccine (CoronaVac) and chimpanzee adenovirus-vector vaccine (ChAdOx1) have been more available in resource-limited settings. However, the data comparing between these two vaccines in the same setting are limited.ObjectivesTo de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0eeb9963015be9ff871a599d517f2a6
https://doi.org/10.1101/2021.10.03.21264451
https://doi.org/10.1101/2021.10.03.21264451